tera.ai

Knowledge Graph

Graph explorer

Search resolved entities, walk their edges, and read the sentence behind every one.

Entities25 of 207,987

All entities

Entity

ATTO-2306

product1 mentionslast seen Nov 9, 2026

Highly potent, half-life extended ATTOBODY-based bispecific antibody targeting IL-31 and IL-13 for atopic dermatitis and other immune-mediated skin diseases.

Relationships 2

ATTO-2306

Relationship

Attovia Therapeutics, Inc.developsATTO-2306

97% confidence1 supporting mentions

Either name opens that entity’s relationships.

Sources 1